Results 21 to 30 of about 69,560 (333)

Autoimmune Hemolytic Anemia After mRNA COVID Vaccine

Journal of Investigative Medicine High Impact Case Reports, 2022
Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT).
Z. Fatima, B. Reece, J. S. Moore, R. Means   +3 more
semanticscholar   +1 more source

Severe autoimmune hemolytic anemia in ICU: a place for emergency plasma exchange? A French multicenter retrospective study. [PDF]

Crit Care
Destival JB, Urbina T, Bougouin W, Leblanc J, Seksik S, Gobert D, Bonny V, Missri L, Baudel JL, Bernier J, Ait-Oufella H, Maury E, Fain O, Joffre J, AIHA study group of the clinical data warehouse of Greater Paris University Hospitals.   +14 more
europepmc   +3 more sources

Warm autoimmune hemolytic anemia and the best treatment strategies.

Hematology. American Society of Hematology. Education Program, 2022
Warm autoimmune hemolytic anemia (wAIHA) is characterized by evidence of red blood cell (RBC) hemolysis and a direct antiglobulin test positive for IgG and sometimes complement. While varying with the extent of the compensatory increase in RBC production,
D. Kuter
semanticscholar   +1 more source

Successful Treatment of Refractory IgA-Mediated Autoimmune Hemolytic Anemia With Bortezomib. [PDF]

EJHaem
ABSTRACT Introduction IgA‐mediated autoimmune hemolytic anemia (AIHA) is a rare condition associated with severe hemolysis and limited therapeutic response. Bortezomib, a proteasome inhibitor, targets plasma cells responsible for autoantibody production.
Neri S, Eckhardt CL, Beuger BM, Folman F, Rettenbacher E, Matlung HL, Kuijpers TW, Vos JMI, van Bruggen R.   +8 more
europepmc   +2 more sources

Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow‐up

European Journal of Haematology, 2022
Autoimmune hemolytic anemia (AIHA) is considered a chronic disease, with an overall good prognosis. However, recent reports indicate pre‐mature mortality. Causes of death have not been evaluated previously.
D. Hansen, S. Möller, H. Frederiksen
semanticscholar   +1 more source

A Case of Autoimmune Hemolytic Anemia after the First Dose of COVID-19 mRNA-1273 Vaccine with Undetected Pernicious Anemia

Case Reports in Hematology, 2022
By this time, multiple vaccines have been approved to limit the spread of SARS-CoV-2 worldwide. These include new-generation vaccines that contain mRNA of the target organism.
Fnu Jaydev, Vinodh Kumar, Jaikumar Khatri, S. Shahani, S. Beganovic   +4 more
semanticscholar   +1 more source

The Autoimmune Hemolytic Anemia following Septic Shock with Escherichia Coli; a Case Report

Archives of Academic Emergency Medicine, 2023
Sepsis is a severe, life-threatening illness caused when the immune system responds inappropriately to infections, causing organ deterioration and negatively affecting the systems inside the body, one of which is the coagulation system. Most hematologic
Duong Le Xuan, Nhi Vo Thuy Tran, Giang Le Duc, Ninh Nguyen Duc, Ghi Nguyen Hai, Hoa Do Thanh   +5 more
doaj   +1 more source

Prevalence of systemic lupus erythematosus in autoimmune hemolytic anemia patients based on coombs test results. [PDF]

Eur J Med Res
Harahap RIM, Ardiningrum T, Pamela Y, Widiasta A, Rossanti R, Bethasari M.   +5 more
europepmc   +3 more sources

New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia

Frontiers in Immunology, 2020
Autoimmune hemolytic anemias mediated by cold agglutinins can be divided into cold agglutinin disease (CAD), which is a well-defined clinicopathologic entity and a clonal lymphoproliferative disorder, and secondary cold agglutinin syndrome (CAS), in ...
S. Berentsen
semanticscholar   +1 more source

Autoimmune Hemolytic Anemia in the Pediatric Setting

Journal of Clinical Medicine, 2021
Autoimmune hemolytic anemia (AIHA) is a rare disease in children, presenting with variable severity. Most commonly, warm-reactive IgG antibodies bind erythrocytes at 37 °C and induce opsonization and phagocytosis mainly by the splenic macrophages ...
Aikaterini Voulgaridou, T. Kalfa
semanticscholar   +1 more source